Jasper Therapeutics, Inc.
JSPRW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001788028
No open-market purchases or sales by Jasper Therapeutics, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $187.1K in total; no superinvestor holds it.
Other share classesJSPR
Q3 2021 vs. Q2 2021
How the institutions holding Jasper Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 0 | 16 | +16 |
| Shares | 0 | 1.88M | +1.88M |
| Value | $0 | $3.67M | +$3.67M |
New holders (16)
Institutions that held Jasper Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Owl Creek Asset Management, L.P. | 672,057 | $995.0K | 0.07% |
| Highbridge Capital Management LLC | – | $900.0K | 0.03% |
| Tenor Capital Management Co., L.P. | 250,000 | $370.0K | 0.01% |
| Shaolin Capital Management LLC | 205,261 | $304.0K | 0.01% |
| UBS Oconnor LLC | 179,723 | $256.0K | 0.00% |
| Zazove Associates LLC | 124,993 | $178.0K | 0.02% |
| Maven Securities LTD | 100,000 | $148.0K | 0.02% |
| Rivernorth Capital Management, LLC | 89,596 | $133.0K | 0.01% |
| Walleye Capital LLC | 80,684 | $119.0K | 0.00% |
| Bulldog Investors, LLP | 47,887 | $71.0K | 0.02% |
| Walleye Trading LLC | 40,853 | $60.0K | 0.00% |
| HRT Financial LP | 37,045 | $54.0K | 0.00% |
| Yakira Capital Management, Inc. | 23,000 | $34.0K | 0.01% |
| Captrust Financial Advisors | 11,988 | $18.0K | 0.00% |
| Cowen and Company, LLC | 10,200 | $15.0K | 0.00% |
| Easterly Investment Partners LLC | 10,000 | $15.0K | 0.00% |
Sold out (0)
Institutions that held Jasper Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
None.